Evidence map›Paper›PMID 31285816›Full record

ArticleClinics and practice2019

Recurrent amelanotic melanoma of nasal cavity: Biological variability and unpredictable behavior of mucosal melanoma. A case report.

Damir Vučinić, Dag Zahirović, Dubravko Manestar, Ingrid Belac-Lovasić, Tamara Braut, Leo Kovač, Nives Jonjić, Gordana Zamolo

Open access · goldAbstract read
In one paragraph

Article in Clinics and practice, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 27 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Damir VučinićFaculty of Medicine, University of Rijeka.
Dag ZahirovićDepartment of Radiotherapy and Oncology, Clinical Hospital Centre Rijeka.
Dubravko ManestarFaculty of Medicine, University of Rijeka.
Ingrid Belac-LovasićFaculty of Medicine, University of Rijeka.
Tamara BrautFaculty of Medicine, University of Rijeka.
Leo KovačDepartment of Pathology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.
Nives JonjićDepartment of Pathology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.
Gordana ZamoloDepartment of Pathology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.
University of Rijeka · HRUniversity Hospital Centre Zagreb · HR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this report is to present a case of a patient with a recurrent nasal cavity amelanotic melanoma (AM), with emphasis on diagnosis and therapy options of this clinical entity. A 65-year-old female patient presented with pain in the right cheek region and nasal obstruction. In 2013, she was diagnosed with mucosal melanoma (MM) of the left nasal cavity. After endoscopic surgery and radiotherapy, the patient was followed by the oncology team. Five years after the initial diagnosis, rhinoscopy showed a tumorous formation in the right nasal cavity. The tumor mass was without black discoloration and was the same color as the surrounding nasal mucosa. Microscopic examination after biopsy of the tumor confirmed amelanotic MM. The patient underwent an additional endoscopic surgery. A complete standard diagnostic workup for MM found metastases in head and neck lymph nodes, on both sides. MMs of head and neck are uncommon malignancies. Unique biology of MM cells causes a high rate of recurrences. This report presents an example of recurrent AM of the nasal cavity, in treatment with checkpoint inhibitor (pembrolizumab), which could provide a good therapy option for patients with MM.

Indexed as

Amelanotic melanomaImmunotherapyMucosal melanomaNasal cavityRadiotherapy

Identifiers

PMID31285816
PMCPMC6589532
OpenAlexW2951269260

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.